Pfizer Inc (PFE.N) and its German partner, BioNTech SE (22UAy.DE), fired back at Moderna Inc (MRNA.O) in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in…

Last year, as the first COVID-19 vaccines began to roll out, I predicted in Foreign Affairs that the global economy would come roaring back and eventually usher in a new golden age of globalization…

I have been an American living in South Africa for more than eight years. Since November, the omicron variant has become a fulcrum that has linked my two countries, which usually orbit quite…

The past month saw a series of proactive U.S. engagements with allies and partners in the Indo-Pacific region, headlined by the announcement of a newly enhanced Australia-U.K.-U.S. trilateral…

The highly infectious delta variant has sparked a new wave of COVID-19 cases and deaths worldwide in recent months, hampering reopenings and slowing the economic recovery. Now comes word of a new…

It’s undoubtedly a coincidence, but two commentators I find most thoughtful and trustworthy both weighed in Wednesday on the question of whether the Food and Drug Administration should just go ahead…

President Joe Biden’s decision to donate 500 million COVID-19 vaccines to other countries by June 2022 is an important step toward restoring the United States’ global standing. Another, parallel…

One can hardly blame people for being worried about the new COVID-19 vaccines when there are so many anecdotal reports of weird side effects — including women experiencing disturbing changes in their…

As India reeled under a deadly second wave of COVID-19, with massive shortages of medical supplies and hospital beds, authorities finally understood the need to rapidly vaccinate the country's…